Michael Wiseman
Nurse Practitioner · Oak Ridge, TNNPI 1689637340
Payments from drug & device makers
Across 660 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$2K
- Dexcom, Inc.$2K
- Novo Nordisk$1K
- Sanofi-aventis U.S. LLC$798
- Abbott$679
- Mannkind Corporation$676
- plus $5K from 33 others
What the payments were for
- Food & beverage$11,636100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 104 | $1,705 |
| Dexcom, Inc. | 59 | $1,586 |
| Novo Nordisk | 73 | $1,165 |
| Sanofi-aventis U.S. LLC | 49 | $798 |
| Abbott | 57 | $679 |
| Mannkind Corporation | 39 | $676 |
| Boehringer Ingelheim | 28 | $458 |
| Bayer | 26 | $403 |
| AstraZeneca(2 entities) | 19 | $402 |
| Medtronic | 18 | $378 |
| Xeris Pharmaceuticals, Inc. | 20 | $372 |
| Amgen(2 entities) | 24 | $364 |
| Corcept Therapeutics | 18 | $326 |
| Amarin Pharma, Inc. | 24 | $313 |
| Merck | 15 | $243 |
| Insulet Corporation | 15 | $240 |
| Cequr Corporation | 2 | $228 |
| Pfizer | 10 | $188 |
| Regeneron Healthcare Solutions, Inc. | 1 | $121 |
| Tandem Diabetes Care, Inc. | 5 | $112 |
| Zealand Pharma US, Inc. | 5 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $82 |
| Radius Health, Inc. | 4 | $70 |
| Clarus Therapeutics Inc. | 10 | $68 |
| IBSA Pharma Inc. | 4 | $62 |
| Neurocrine Biosciences, Inc. | 2 | $55 |
| Lifescan, Inc. | 3 | $51 |
| Amneal Pharmaceuticals LLC | 3 | $47 |
| BETA Bionics, Inc. | 2 | $46 |
| Antares Pharma, Inc. | 3 | $45 |
| Kyowa Kirin, Inc. | 2 | $39 |
| Amphastar Pharmaceuticals, Inc. | 2 | $36 |
| OPKO Pharmaceuticals, LLC | 2 | $36 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| AbbVie | 2 | $30 |
| Boston Scientific | 1 | $30 |
| Ascensia Diabetes Care US Inc. | 1 | $25 |
| Amryt Pharma Holdings Ltd | 1 | $23 |
| Chiesi USA, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$206
- EYLEA HD$121
How this compares
$11,648 in reported general payments places this provider in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 399 | $580,200 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 398 | $457,197 |
| Tresiba Flextouch U-200Insulin Degludec | 300 | $354,317 |
| MounjaroTirzepatide | 189 | $251,769 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 230 | $236,125 |
| JardianceEmpagliflozin | 156 | $159,202 |
| TrulicityDulaglutide | 94 | $136,739 |
| RybelsusSemaglutide | 85 | $123,559 |
| Humulin R U-500Insulin Regular, Human | 82 | $115,014 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 158 | $97,693 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 46 | $88,571 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 108 | $84,233 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 95 | $71,867 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 73 | $67,034 |
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 61 | $44,546 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Fiasp, Novolog | $1,165 | $776,898643 claims |
| Boehringer IngelheimSynjardy Xr, Jardiance, Trijardy Xr, Synjardy, Glyxambi | $458 | $523,834534 claims |
| Lilly USA, LLCMounjaro, Trulicity, Lyumjev, Humalog | $1,705 | $417,653336 claims |
| AstraZenecaFarxiga | $402 | $37,15350 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $798 | $22,90415 claims |
| MerckJanumet Xr | $243 | $21,36129 claims |
| Cequr CorporationCequr Simplicity | $228 | $7,52516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.
Other nurse practitioner in Oak Ridge
- Jennifer SkeroOak Ridge$16K
- Amy HatcherMurfreesboro$1.1M
- Karen RodenKnoxville$265K
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Erica HembreeKnoxville$125K
- Brooke FaughtNashville$89K
- Lauren WelchNashville$71K
- Cara StoutKingsport$71K
- S Marie HamiltonOoltewah$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.